Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes

References

• Abra R. M., Mihalko P. J. The effect of lipid composition upon the encapsulation and in vitro leakage of metoproteranol sulphate from 0.2 mm in diameter, extruded multilamellar liposomes. Journal of Controlled Release 1990; 14: 71
   Web of Science ®Google Scholar
• Alving C. R., Steck E., Chapman W. L., Waits W. B., Hendriks L. D., Swarts G. M., Hansen W. C. The therapy of leishmaniasis: superior efficacies of liposome encapsulated drugs. Proceedings of the National Academy of Sciences USA 1978; 75: 2959
   PubMed Web of Science ®Google Scholar
• Alving C. R. Therapeutic potential of liposomes as carriers in leishmaniasis, malaria vaccine. Targeting of Drugs, G. Gregoriadis, J. Senior, A. Trouet. Plenum Press, New York 1982; 331
   Google Scholar
• Arnold J., Alving A. S., Hochwald R. S., Clayman C. B., Dern R. J., Beutler E., Flanagan C. L., Jeffery G. M. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria. Journal of Laboratory Clinical Medicine 1955; 43: 391
   Google Scholar
• Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology 1965; 13: 238
   PubMed Web of Science ®Google Scholar
• Coleman M. D., Fleckenstein L., Heiffler M. H. Primaquine disposition in the isolated perfused rat liver: effect of mefloquine induced bile flow reduction. Biopharmacy Drug Dispensing 1989; 10: 153
   PubMed Web of Science ®Google Scholar
• Crommelin D. J. A. Influence of lipid composition on ionic strength on the physical stability of liposomes. Journl of Pharmaceutical Science 1984; 73: 1559
   PubMed Web of Science ®Google Scholar
• Deasy P. B. Microencapsulation and related drug process. Marcell Dekker, Basel 1984
   Google Scholar
• Dijkstra J., Van Galen W. J. M., Hulstaert C. E., Kalichoven D., Roerdink F. H., Scherphof G. L. Interaction of liposomes with Kupffer cells. in vitro, Experimental Cell Research 1984a; 150: 161
   PubMed Web of Science ®Google Scholar
• Dijkstra J., Van Galen M., Scherphof G. Effects of ammonium chloride and chloroquine on endocytic uptake of liposomes by Kupffer cells in vitro. Biochimica et Biophysicn Acta 1984b; 804: 58
   PubMed Web of Science ®Google Scholar
• Eighth Programme Report on the UNDP/ World Bank/ WHO. Special Programme for Research and Training in Tropical Diseases 1987; 139: 46
   Google Scholar
• El-Ridy M. S., Akbarich M., Besner J. G., Kassem M., Sharkawi M., Tawashi R. Preparation and characterization of liposome encapsulated praziquantel for prophylactic treatment of schistozomiazis. 6th International Pharmaceutical Technical Conference. APGI, Paris 1989; 288
   Google Scholar
• Ercan M. T., Sarizi T., Bekdik C. Labelling and evaluation of 99mTccyclophosphamide for tumour visualization. International Journal of Applied Radiation and Isotopes 1977; 28: 521
   PubMedGoogle Scholar
• Ercan M. T. Rapid determination hydrolyzed-reduced technetium 99m in particulate radiopharmaceuticals. Applied Radiation and Isotopes 1992; 43: 1175
   Web of Science ®Google Scholar
• Fessi H., Marty J. P., Puisieux F., Carstensen J. T. Square root of time dependence of matrix formulations with low drug content. Journal of Pharmaceutical Sciences 1982; 71: 749
   PubMed Web of Science ®Google Scholar
• Gregoriadis G., Ryman B. E. Lysosomal location of b-fuctofuranosidase-containing liposomes injected into rats: some implication in treatment of genetic disorders. Biochemical Journal 1972; 129: 123
   PubMed Web of Science ®Google Scholar
• Hofsteenge J., Capuano A., Atszuler R., Moore S. Carrier-linked primaquine in the chemotherapy of malaria. Journal of Medical Chemistry 1986; 29: 1765
   PubMed Web of Science ®Google Scholar
• Holbrook D. J., Griffin J. B., Fowler L., Gibson B. R. Tissue distribution of primaquine in the rat. Pharmacology 1981; 22: 330
   PubMed Web of Science ®Google Scholar
• Jousma H., Talsma H., Spies F. J., Joosten J. G. H., Junginger H. E., Crommelin D. J. A. The influence of extrusion of multilamellar vesicles through polycarbonate membranes on particle size, particle size distribution and number of bilayers. International Journal of Pharmaceutics 1987; 35: 263
   Web of Science ®Google Scholar
• Kimelberg H. K. Liposomes as a carrier for methotraxate. Liposomes in Biological Systems, K. Allison, G. Gregoriadis. John Wiley, Chichester 1978
   Google Scholar
• Knop G. Preparation of tin albumin nanospheres for labelling with 99mTc and application in liver. Journal of Microencapsulation 1984; 1: 249
   PubMedGoogle Scholar
• Langer R. New method of drug delivery. Science 1990; 249: 1527
   PubMed Web of Science ®Google Scholar
• Lee C. C., Kinter L. D., Heiffer M. H. Subacute toxicity of primaquine in dogs, monkeys and rats. Bulletin of WHO 1981; 59: 439
   PubMed Web of Science ®Google Scholar
• Mbela T. K. M., Poupaert J. H., Dumant P. Poly(diethylmethylidene malonate) nanoparticles as primaquine delivery system to liver. International Journal of Pharmaceutics 1992; 79: 29
   Web of Science ®Google Scholar
• New R. R. C. Liposomes—A Practical Approach. Oxford University Press, Oxford, New York, Tokyo 1990
   Google Scholar
• Olson F., Hunt C. A., Szoka F. C., Vail W. J., Papahadjopoulos D. Preparation of defined size distribution by extrusion through polycarbonate membranes. Biochimica et Biophysica Acta 1979; 557: 9
   PubMed Web of Science ®Google Scholar
• Payne N. I., Casgrave R. F., Green A. P., Lin L. In vivo studies of amphoterisin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue disposition of the drug in mice. Journal of Pharmacy and Pharmacology 1987; 39: 24
   PubMed Web of Science ®Google Scholar
• Peppas N. A. Classification of controlled release systems. Controlled Release Systems, A. Gursoy, E. Piskin, B. Dortunc, N. A. Peppas. Technografic and Ada Ofset, Istanbul 1989
   Google Scholar
• Peeters P. M. A., Leest K., Eling W. M. C., Crommelin D. J. A. Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of the murine malaria. Pharmaceutical Research 1989; 6: 787
   PubMed Web of Science ®Google Scholar
• Pirson P., Steiger R. F., Trouet A., Gillet J., Herman F. Primaquine liposomes in the chemotherapy of experimental murine malaria. Annals of Tropical Medicine and Parasitology 1980; 74: 383
   PubMed Web of Science ®Google Scholar
• Pirson P., Steiger R., Trouet A. The disposition of free and liposomally encapsulated antimalarial primaquine in mice. I. Biochemical Pharmacology 1982; 31: 3501
   PubMed Web of Science ®Google Scholar
• Roerdink F. H., Daemen T., Bakker-Woundenberg I. A. J. M., Storm G., Crommelin D. J. A., Scherphof G. L. Therapeutic utility of liposomes. Ellis Horwood, Chichester 1987; 66–80
   Google Scholar
• Sanita A., Gupta U. R., Gupta R. C., Anand N., Agarwal S. S. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites. I. Biochemical Pharmacology 1988; 37: 4605
   PubMed Web of Science ®Google Scholar
• Sato Y., Kiwada H., Kato Y. Effects of dose and vesicle size on the pharmacokinetics of liposomes. Chemical Pharmaceutical Bulletin 1986; 34: 4244
   PubMed Web of Science ®Google Scholar
• Schwartz M. A., McConnell H. M. Surface areas of lipid membranes. Biochemistry 1978; 17: 837
   PubMed Web of Science ®Google Scholar
• Szoke F., Papahadjopoulos D. Comparative properties and methods of preparafion of lipid vesicles. Annual Review of Bioengineering 1980; 9: 467
   PubMedGoogle Scholar
• Talsma H., Özer A. Y., Van Bloois L. The size reduction of liposomes with a high pressure homogenizer (Microfluidizer TM). Characterization of prepared dispersions and comparison with conventional methods. Drug Development and Industrial Pharmacy 1989; 15: 197
   Web of Science ®Google Scholar
• Talsma H. Preparation, characterization and sterilization of liposomes. Ph.D. Thesis. University of Utrecht, The Netherlands 1991
   Google Scholar
• Trouet A., Pirson P., Steiger R., Masqueiler M., Baurain R., Gillet J. Development of new derivatives of primaquine by association with lysosomotropic carriers. Bulletin of WHO 1981; 59: 449
   PubMed Web of Science ®Google Scholar
• Tsukada K., Ueda S., Okada R. Preparation of liposome encapsulated anti-tumor drugs and in vitro drug release. Chemical Pharmacy Bulletin 1984; 32: 1929
   Web of Science ®Google Scholar
• Van Gent C. M., Roseleur O. J. Quantitative determination of phospholipis in blood serum or plasma by a nondestructive method. 9th International Congress on Clinical Chemistry, Toronto, 13–18 July, 1975, 197
   Google Scholar
• Vemuri S., Yu C. D., De Groot J. S., Roosdrop N. In vitro interaction of sized and insized liposome vesicles with high density lipoproteins. Drug Development and Industrial Pharmacy 1990; 16: 1579
   Web of Science ®Google Scholar
• Vemuri S., Yu C. D., Pushpala S., Roosdorp N. Drug release rate method for liposome preparation. Drug Development and Industrial Pharmacy 1991; 17: 183
   Web of Science ®Google Scholar
• Weiner N., Martin F., Riaz M. Liposomes as a drug delivery system. Drug Development and Industrial Pharmacy 1982; 15: 1523, 5, 487–493
   Web of Science ®Google Scholar